Why Living with Pulmonary Arterial Hypertension Requires a Holistic Approach: A Patient and Clinician Perspective

被引:1
|
作者
Lynn, Haley [1 ]
Wilson, Melisa [1 ]
机构
[1] Advent Hlth Orlando, Adv Lung Dis, 2501 North Orange Ave Suite 402, Orlando, FL 32804 USA
关键词
Pulmonary arterial hypertension; Patient perspectives; Clinician perspectives; PAH-SYMPACT QUESTIONNAIRE; 5; INHIBITORS; IMPACT; MANAGEMENT; ADHERENCE; RISK;
D O I
10.1007/s41030-022-00213-9
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Pulmonary arterial hypertension (PAH) is a rare disease caused by high pressure in the blood vessels leading from the heart to the lung. PAH affects many parts of a patient's life, which means that patients should be managed by a clinical team of different specialists, including doctors, advance practice providers, nurses, social workers, and therapists. This article is co-authored by a patient living with PAH and an acute care nurse practitioner specializing in the management of patients with pulmonary hypertension. In the first section of this commentary, the patient describes her experience of living with PAH. The specialist nurse practitioner then discusses the management of PAH, to provide a clinician perspective in the context of the patient's experiences. [GRAPHICS] PLAIN LANGUAGE SUMMARY This article describes the experience of a young patient with pulmonary arterial hypertension, or PAH, as well as the point of view of a PAH specialist nurse practitioner. PAH is a rare disease caused by high pressure in the blood vessels leading from the heart to the lung. This means the right side of the heart needs to work harder to pump blood through the lungs, which can make it weaker and eventually cause right heart failure and death. Although PAH cannot be cured and gets worse over time, effective treatment can delay worsening, reduce symptoms, and improve quality of life. Recognizing symptoms and diagnosing PAH early is important so that patients can be referred to specialists who understand PAH and can provide the most appropriate treatment. A patient's risk status shows the chance of the disease getting worse and the patient dying. The aim is to treat patients so that they stay low risk and improve their chance of living longer. Clinical guidelines give specialists advice on treating patients with PAH and say that regular risk assessment is important to guide treatment decisions. Because PAH affects many parts of a patient's life, the guidelines also say that patients should be managed by a clinical team of different specialists including doctors, advance practice providers, nurses, social workers, and therapists. Making sure that patients and carers understand PAH and the benefit of treatment is also important to help patients follow their treatment plan and actively help to manage their disease.
引用
收藏
页码:1 / 13
页数:13
相关论文
共 50 条
  • [1] Why Living with Pulmonary Arterial Hypertension Requires a Holistic Approach: A Patient and Clinician Perspective
    Haley Lynn
    Melisa Wilson
    [J]. Pulmonary Therapy, 2023, 9 : 1 - 13
  • [2] Volume Management in Pulmonary Arterial Hypertension Patients: An Expert Pulmonary Hypertension Clinician Perspective
    Hansen L.
    Burks M.
    Kingman M.
    Stewart T.
    [J]. Pulmonary Therapy, 2018, 4 (1) : 13 - 27
  • [3] Patient and Clinician Perceptions of Palliative Care in Pulmonary Arterial Hypertension
    Swetz, K. M.
    Shanafelt, T. D.
    Sloan, J. A.
    Novotny, P. J.
    Frantz, R. P.
    McGoon, M. D.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (04): : S29 - S30
  • [4] Genetic Testing in Pulmonary Arterial Hypertension Evaluation A Patient and Clinician Survey
    Rice, Jordin L.
    Austin, Eric D.
    Mathai, Stephen C.
    Sahay, Sandeep
    [J]. CHEST, 2024, 165 (05) : 1224 - 1227
  • [5] Approach to the hospitalized patient with pulmonary arterial hypertension
    Deshwal, Himanshu
    Sulica, Roxana
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2023, 29 (05) : 329 - 339
  • [6] My life with pulmonary arterial hypertension: a patient perspective
    Ferrari, Pisana
    Skara, Hall
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0K) : 54 - 59
  • [7] Role of Genetic Testing in Pulmonary Arterial Hypertension Evaluation: A Patient and Clinician Survey
    Rice, J.
    Austin, E. D.
    Mathai, S. C.
    Sahay, S.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [8] Determinants of Quality of Life and Patient Responses to Living with Pulmonary Arterial Hypertension
    Park, M. H.
    Chesney, M. A.
    Aje, T. O.
    Gottlieb, M.
    Ramani, G.
    Synowski, S. J.
    Frederick, J.
    Kop, W. J.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (02): : S145 - S145
  • [9] Patient and Clinician Perspectives on Pulmonary Arterial Hypertension Clinical Trial Endpoints - A Qualitative Study
    Goodman, R.
    Lapatra, T.
    Al-Naamani, N.
    Kawut, S. M.
    Courtright, K.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [10] "It's that invisible illness": Patient and clinician perspectives on outcomes in pulmonary arterial hypertension treatment
    Auriemma, Catherine L. L.
    Minhas, Jasleen
    Blue, Randi
    Lapatra, Tess
    Kawut, Steven M. M.
    Courtright, Katherine R. R.
    [J]. PULMONARY CIRCULATION, 2023, 13 (02)